• FirefoxInstall the new Firefox »
  •  Dow Down1.11% Nasdaq Down0.94%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    2.45 0.00(0.00%) Mar 31, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 896   854   1,989   1,995  
    Cost of Revenue -   -   -   -  
    Gross Profit 896   854   1,989   1,995  
    Operating Expenses
    Research Development5,968  6,939  7,206  7,552  
    Selling General and Administrative6,082  7,226  6,387  3,417  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (11,154) (13,311) (11,604) (8,974)
    Income from Continuing Operations
    Total Other Income/Expenses Net10,142  (1,623)293  (5,052)
    Earnings Before Interest And Taxes(1,012)(14,934)(11,311)(14,026)
    Interest Expense311  391  470  547  
    Income Before Tax(1,323)(15,325)(11,781)(14,573)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,323)(15,325)(11,781)(14,573)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,323) (15,325) (11,781) (14,573)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,323) (15,325) (11,781) (14,573)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.